Serum Institute CEO claims made in India COVID vaccines better than Pfizer, Moderna vaccines

Published On 2022-04-14 06:30 GMT   |   Update On 2023-09-30 12:02 GMT

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.

Speaking to ANI, the SII CEO said, "The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna."
"It's good that vaccines like Pfizer and Moderna are not introduced in India, because in countries like US people have taken 2nd and 3rd booster dose and still many are getting infected with Corona but in India, our vaccines have given good protection," Poonawala stated.
On being asked about the export of the Covishield COVID-19 vaccine, the SII CEO informed that India has exported it to more than 80 countries so far.
Advertisement
Read also: CDSCO panel seeks additional data on Serum Institute EUA application for Covovax use in 7-11 year-olds    
"We have exported Covishield to more than 80 countries and 10 crore doses so far. Now, the demand for COVID vaccine has been reduced due to declining cases," he added.
He also added that "In some countries where mRNA vaccine was given, many people were hospitalised and cases were reported in those countries because they were not providing good protection against the viral infection."
Read also: Serum institute Covovax first Indian COVID vaccine to be sold in Europe: Adar Poonawalla  

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company headquartered in Pune, India. The company was founded by Dr. Cyrus Poonawalla in 1966.  Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs.

Read also: COVID: SII to give free Covishield vials to pvt vaccination centres to compensate for price difference  

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News